Free Trial

Global Cord Blood (CO) Competitors

→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad)
Free CO Stock Alerts
$1.25
0.00 (0.00%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsSocial Media

CO vs. CORBF, VMD, QIPT, PRQR, VCXB, INGN, SCLX, PIII, SCPH, and GOSS

Should you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Global Cord Blood (CORBF), Viemed Healthcare (VMD), Quipt Home Medical (QIPT), ProQR Therapeutics (PRQR), 10X Capital Venture Acquisition Corp. III (VCXB), Inogen (INGN), Scilex (SCLX), P3 Health Partners (PIII), scPharmaceuticals (SCPH), and Gossamer Bio (GOSS). These companies are all part of the "medical" sector.

Global Cord Blood vs.

Global Cord Blood (NYSE:CO) and Global Cord Blood (NYSE:CORBF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, community ranking, media sentiment, profitability, valuation and dividends.

Global Cord Blood has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of -0.25, suggesting that its share price is 125% less volatile than the S&P 500.

Global Cord Blood received 338 more outperform votes than Global Cord Blood when rated by MarketBeat users.

CompanyUnderperformOutperform
Global Cord BloodOutperform Votes
338
74.29%
Underperform Votes
117
25.71%
Global Cord BloodN/AN/A

Company Net Margins Return on Equity Return on Assets
Global Cord BloodN/A N/A N/A
Global Cord Blood N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Cord Blood$1.24B0.12$79.04M$0.641.95
Global Cord Blood$196.12MN/A$79.04MN/AN/A

In the previous week, Global Cord Blood had 1 more articles in the media than Global Cord Blood. MarketBeat recorded 5 mentions for Global Cord Blood and 4 mentions for Global Cord Blood. Global Cord Blood's average media sentiment score of 0.08 beat Global Cord Blood's score of 0.00 indicating that Global Cord Blood is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Global Cord Blood
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Global Cord Blood
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Global Cord Blood beats Global Cord Blood on 5 of the 5 factors compared between the two stocks.

Get Global Cord Blood News Delivered to You Automatically

Sign up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CO vs. The Competition

Export to Excel
MetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE Exchange
Market Cap$151.94M$2.17B$4.87B$17.47B
Dividend YieldN/A2.06%2.91%3.55%
P/E Ratio1.9520.30212.2324.10
Price / Sales0.125.722,334.2110.49
Price / Cash4.1911.9846.7917.65
Price / Book0.203.454.754.87
Net Income$79.04M$73.33M$103.38M$964.96M
7 Day PerformanceN/A-0.47%0.74%1.90%
1 Month Performance-7.41%-6.53%-7.58%-3.08%
1 Year PerformanceN/A-26.53%9.20%96.69%

Global Cord Blood Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CORBF
Global Cord Blood
0 of 5 stars		$1.35
flat		N/AN/A$164.09M$196.12M0.001,202News Coverage
VMD
Viemed Healthcare
0 of 5 stars		$8.06
+2.8%		N/A-22.5%$312.41M$183.01M31.00996
QIPT
Quipt Home Medical
2.203 of 5 stars		$3.85
+2.7%		$10.00
+159.7%		-35.4%$163.89M$221.74M-42.771,200
PRQR
ProQR Therapeutics
1.8788 of 5 stars		$2.02
+1.0%		$3.60
+78.2%		-12.2%$164.35M$7.05M-5.18156Positive News
Gap Down
VCXB
10X Capital Venture Acquisition Corp. III
0 of 5 stars		$10.87
-0.9%		N/A+5.7%$165.33MN/A0.00N/A
INGN
Inogen
2.653 of 5 stars		$6.90
+3.0%		$7.50
+8.7%		-48.0%$162.50M$315.66M-1.56834Short Interest ↑
Negative News
SCLX
Scilex
1.6709 of 5 stars		$0.98
+3.2%		$8.00
+719.1%		-88.3%$162.32M$46.74M-0.76105News Coverage
PIII
P3 Health Partners
1.3277 of 5 stars		$0.51
-1.9%		$4.75
+825.9%		-61.2%$162.06M$1.27B-0.79400
SCPH
scPharmaceuticals
3.1943 of 5 stars		$4.61
+0.9%		$19.33
+319.4%		-52.7%$166.19M$13.59M-3.25135
GOSS
Gossamer Bio
3.8677 of 5 stars		$0.74
-1.3%		$7.65
+937.1%		-42.7%$166.39MN/A-0.53135News Coverage
Gap Up

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (NYSE:CO) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
They say it’s ‘unstoppable’ – How I made 43,509%
Investing Daily
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
Protect Your Bank Account Before It’s Too Late
Weiss Ratings
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press